Literature DB >> 16337425

Programming of the endocrine pancreas by the early nutritional environment.

Brigitte Reusens1, Claude Remacle.   

Abstract

A substantial body of evidence now suggests that poor intrauterine milieu elicited by maternal nutritional disturbance or placental insufficiency may programme susceptibility in the foetus to later develop chronic degenerative diseases, such as obesity, hypertension, cardiovascular diseases and diabetes. Further data showing the developmental programming of the metabolic syndrome are now available thanks to animal studies in which the foetal environment has been manipulated. This review examines the developmental programming of glucose intolerance by disturbed intrauterine metabolic condition in rats. It focuses on the alteration of the endocrine pancreas at birth. Long-term consequences, deterioration of glucose tolerance and even transgenerational effects are reported. Maternal protein, caloric restriction and diabetes during gestation/lactation lead to altered beta-cell mass. This review also tempts to identify cellular and molecular mechanisms involved in this process.

Entities:  

Mesh:

Year:  2005        PMID: 16337425     DOI: 10.1016/j.biocel.2005.10.012

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  15 in total

Review 1.  What is an epigenetic transgenerational phenotype? F3 or F2.

Authors:  Michael K Skinner
Journal:  Reprod Toxicol       Date:  2007-09-11       Impact factor: 3.143

2.  Increased adrenergic signaling is responsible for decreased glucose-stimulated insulin secretion in the chronically hyperinsulinemic ovine fetus.

Authors:  Sasha E Andrews; Laura D Brown; Stephanie R Thorn; Sean W Limesand; Melissa Davis; William W Hay; Paul J Rozance
Journal:  Endocrinology       Date:  2015-01       Impact factor: 4.736

3.  Maternal low-protein diet during lactation combined with early overfeeding impair male offspring's long-term glucose homeostasis.

Authors:  Douglas Lopes Almeida; Fernando Salgueiro Simões; Lucas Paulo Jacinto Saavedra; Ana Maria Praxedes Moraes; Camila Cristina Ianoni Matiusso; Ananda Malta; Kesia Palma-Rigo; Paulo Cesar de Freitas Mathias
Journal:  Endocrine       Date:  2018-08-20       Impact factor: 3.633

4.  Prenatal programming of childhood overweight and obesity.

Authors:  Jennifer S Huang; Tiffany A Lee; Michael C Lu
Journal:  Matern Child Health J       Date:  2006-09-28

Review 5.  Regenerative approaches to preserve pancreatic β-cell mass and function in diabetes pathogenesis.

Authors:  Maria Fernanda Desentis-Desentis
Journal:  Endocrine       Date:  2021-11-25       Impact factor: 3.633

6.  Maternal obesity accelerates fetal pancreatic beta-cell but not alpha-cell development in sheep: prenatal consequences.

Authors:  Stephen P Ford; Liren Zhang; Meijun Zhu; Myrna M Miller; Derek T Smith; Bret W Hess; Gary E Moss; Peter W Nathanielsz; Mark J Nijland
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-07-15       Impact factor: 3.619

Review 7.  Effect of in utero and early-life conditions on adult health and disease.

Authors:  Peter D Gluckman; Mark A Hanson; Cyrus Cooper; Kent L Thornburg
Journal:  N Engl J Med       Date:  2008-07-03       Impact factor: 91.245

Review 8.  The regulation of pre- and post-maturational plasticity of mammalian islet cell mass.

Authors:  Teresa Mezza; Rohit N Kulkarni
Journal:  Diabetologia       Date:  2014-05-14       Impact factor: 10.122

9.  The timing of nutrient restriction during rat pregnancy/lactation alters metabolic syndrome phenotype.

Authors:  Mina Desai; Dave Gayle; Jooby Babu; Michael G Ross
Journal:  Am J Obstet Gynecol       Date:  2007-06       Impact factor: 8.661

10.  Early postnatal low-protein nutrition, metabolic programming and the autonomic nervous system in adult life.

Authors:  Júlio Cezar de Oliveira; Sabrina Grassiolli; Clarice Gravena; Paulo Cezar Freitas de Mathias
Journal:  Nutr Metab (Lond)       Date:  2012-09-11       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.